Sort by
Refine Your Search
-
compounds, cancer or immunotherapy research. The candidate should be familiar with air-sensitive chemistry and general analytical techniques such as FTIR, NMR, electrochemistry, etc. Desirable criteria
-
The David Beale PhD Supplementary Scholarship in Prostate Cancer Research was established in 2023 from a generous donation to the University from David Beale to support a full-time PhD or MPhil
-
Scholarship will fund a 3-year PhD candidature to work in the Cancer, Ageing & Vaccine Laboratory (SHBS). Project is a collaboration with WEHI and Hudson Institute to improve cancer diagnosis
-
referees. The immune system plays a pivotal role in cancer prevention, development and therapy. We are currently interested in two natural compounds that have the potential to modulate immune responses and
-
contact details of two referees. Co-supervised by Dr April Kartikasari, Dr Andrew Stephens (Hudson Research Institute) and Professor Clare Scott (WEHI). Epithelial ovarian cancer is one of the leading
-
Using cancer and vaccine clinical trials, the project will use RNAseq, epigenetics and flowcytometry, as well as classic immunological techniques. Using cancer and vaccine clinical trials
-
-compounds as anti-ovarian cancer therapeutics. Scholarship will fund a 3 year PhD candidature to work in the Chemistry Department of the RMIT School of Science CAMIC Laboratory. Project is a collaboration
-
the treatment landscape for metastatic melanoma, an aggressive form of skin cancer. Although new therapies work for some patients, there are many that do not respond or become resistant to treatment. In
-
Background Stream 1: Over 70% of people diagnosed with Pancreatic Cancer (PC) will suffer debilitating nutrition impact symptoms including pain, weight loss and diarrhoea. These symptoms have been
-
therapeutics for treating cancer and antimicrobial resistance. Through both universities students will have access to state-of-the-art synthetic, characterisation and computational laboratories and will work